$CYCC Cyclacel Pharmaceuticals, Inc. Insiders
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Cyclacel Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of current and past insiders in Cyclacel Pharmaceuticals, Inc.. Find out how many shares they currently own, their value and whether they buy or sell their shares.
Cyclacel Pharmaceuticals, Inc. Insiders
| Name | Position | Total Shares | Current Value ($) | Last 3 Months | Buy / Sell | Last Transaction | |
|---|---|---|---|---|---|---|---|
| ARCH MANAGEMENT PARTNERS II LP | 10% Owner | 1,860,824 | 9,248,295 | Mar 22 2004 | |||
| ARCH MANAGEMENT PARTNERS II LP | 10% Owner | 0 | 0 | Nov 02 2004 | |||
| ARCH V ENTREPRENEURS FUND LP | 10% Owner | 0 | 0 | Nov 02 2004 | |||
| ARCH VENTURE FUND II LP | 10% Owner | 1,860,824 | 9,248,295 | Mar 22 2004 | |||
| ARCH VENTURE FUND II LP | 10% Owner | 0 | 0 | Nov 02 2004 | |||
| ARCH VENTURE FUND III L P | 10% Owner | 913,784 | 4,541,506 | Nov 02 2004 | |||
| ARCH VENTURE FUND V LP | 10% Owner | 0 | 0 | Nov 02 2004 | |||
| ARCH VENTURE FUND V LP | 10% Owner | 1,704,763 | 8,472,672 | Mar 22 2004 | |||
| ARCH VENTURE PARTNERS LLC | 10% Owner | 913,784 | 4,541,506 | Nov 02 2004 | |||
| ARCH VENTURE PARTNERS V LP | 10% Owner | 1,333,934 | 6,629,652 | Nov 02 2004 | |||
| Bacopoulos Nicholas G | Director | 0 | 0 | May 31 2016 | |||
| Bacopoulos Nicholas G | Director | 0 | 0 | May 23 2014 | |||
| Banham John Michael Middlecott | Director | 36,847 | 183,130 | Jun 29 2020 | |||
| Banham John Michael Middlecott | Director | 0 | 0 | May 23 2013 | |||
| Banham John Michael Middlecott | Director | 0 | 0 | May 23 2014 | |||
| BARKER SAM L | Director | 0 | 0 | Jun 29 2020 | |||
| BERENSON RONALD J | President & C.E.O. | 403,667 | 2,006,225 | Mar 23 2004 | |||
| BERENSON RONALD J | President & C.E.O. | 430,939 | 2,141,767 | Apr 08 2004 | |||
| BERENSON RONALD J | President & C.E.O. | 0 | 0 | Apr 09 2004 | |||
| BERENSON RONALD J | President and CEO | 0 | 0 | Feb 07 2005 | |||
| BLACK JOANNA S | General Counsel, V.P. & Sec. | 0 | 0 | Apr 09 2004 | |||
| BLACK JOANNA S | VP and General Counsel, Secret | 0 | 0 | Feb 07 2005 | |||
| BONYHADI MARK L | V.P , Research | 0 | 0 | Apr 09 2004 | |||
| BONYHADI MARK L | Vice President, Research | 0 | 0 | Feb 07 2005 | |||
| BYBEE CLINTON | 10% Owner | 2,054,271 | 10,209,727 | Mar 23 2004 | |||
| BYBEE CLINTON | 10% Owner | 0 | 0 | Nov 02 2004 | |||
| Chiao Judy | V.P., Clin. Dev. & Reg. Aff. | 46,168 | 229,455 | Dec 09 2019 | |||
| Chiao Judy | V.P., Clin. Dev. & Reg. Aff. | 0 | 0 | Dec 07 2007 | |||
| Chiao Judy | V.P., Clin. Dev. & Reg. Aff. | 48,168 | 239,395 | Jun 11 2008 | |||
| Chiao Judy | V.P., Clin. Dev. & Reg. Aff. | 133,168 | 661,845 | Dec 10 2013 | |||
| Chiao Judy | V.P., Clin. Dev. & Reg. Aff. | 0 | 0 | Feb 20 2015 | |||
| Chiao Judy | V.P., Clin. Dev. & Reg. Aff. | 55,452 | 275,596 | Jan 29 2013 | |||
| Collins William | General Manager | 0 | 0 | Apr 04 2008 | |||
| Collins Willian | General Manager | 0 | 0 | Oct 10 2007 | |||
| CORDOVA L KATHI | S.V.P. of Finance & Treasurer | 0 | 0 | Apr 09 2004 | |||
| CORDOVA L KATHI | SVP Finance, Treasurer | 0 | 0 | Feb 07 2005 | |||
| CRAIG STEWART | C.O.O. & Vice President | 0 | 0 | Apr 09 2004 | |||
| CRAIG STEWART | COO and VP | 0 | 0 | Feb 07 2005 | |||
| CRANDELL KEITH | 10% Owner | 2,054,271 | 10,209,727 | Mar 23 2004 | |||
| CRANDELL KEITH | 10% Owner | 0 | 0 | Nov 02 2004 | |||
| CREDIT SUISSE FIRST BOSTON/ | 10% Owner | 960,964 | 4,775,991 | Mar 23 2004 | |||
| CURRY ROBERT E | Director | 960,964 | 4,775,991 | Mar 23 2004 | |||
| DELEAGE JEAN | Director | 1,142,400 | 5,677,728 | Nov 03 2004 | |||
| DELEAGE JEAN | Director | 0 | 0 | Jun 17 2005 | |||
| DELEAGE JEAN | 0 | 0 | Dec 04 2006 | ||||
| Eastern Capital LTD | 10% Owner | 2,167,261 | 10,771,287 | Jul 21 2017 | |||
| Flynn James E | 10% Owner | 881,743 | 4,382,263 | Nov 20 2008 | |||
| FROHLICH MARK | Medical Director and V.P. | 0 | 0 | Apr 09 2004 | |||
| FROHLICH MARK | Medical Director and VP | 0 | 0 | Feb 07 2005 | |||
| HEALTHCARE FOCUS FUND LP | 10% Owner | 1,684,870 | 8,373,804 | Mar 22 2004 | |||
| HEALTHCARE FOCUS FUND LP | 10% Owner | 0 | 0 | Nov 02 2004 | |||
| HENNEY CHRISTOPHER S | Director | 0 | 0 | Jun 29 2020 | |||
| HENNEY CHRISTOPHER S | Director | 0 | 0 | May 23 2014 | |||
| HENNEY CHRISTOPHER S | Director | 0 | 0 | Jul 11 2006 | |||
| HENNEY CHRISTOPHER S | Director | 0 | 0 | Mar 31 2010 | |||
| Hradsky Gregory T. | Director | 0 | 0 | Jun 29 2020 | |||
| Hradsky Gregory T. | Director | 0 | 0 | May 23 2014 | |||
| Hradsky Gregory T. | Director | 0 | 0 | May 24 2012 | |||
| Hradsky Gregory T. | Director | 0 | 0 | May 23 2013 | |||
| Jackson Robert | S.V.P. & Chief Scientific Offi | 64,841 | 322,260 | Jul 11 2006 | |||
| KIRKMAN ROBERT L | Chief Business Officer & V.P. | 0 | 0 | Apr 09 2004 | |||
| KIRKMAN ROBERT L | Chief Business Officer and VP | 0 | 0 | Feb 07 2005 | |||
| Kirschbaum Mark | Chief Medical Officer | 0 | 0 | Oct 28 2020 | |||
| LANGECKER PETER | Director | 2,000 | 9,940 | Jun 24 2004 | |||
| LANGECKER PETER | Director | 5,000 | 24,850 | Jun 17 2005 | |||
| LAZARUS STEVEN | 10% Owner | 2,054,271 | 10,209,727 | Nov 02 2004 | |||
| Legault Pierre | Director | 0 | 0 | Feb 21 2008 | |||
| MARXE AUSTIN W & GREENHOUSE DAVID M | 10% Owner | 2,806,900 | 13,950,293 | Sep 26 2011 | |||
| McBarron Paul | See Remarks | 74,104 | 368,297 | Dec 15 2020 | |||
| McBarron Paul | E.V.P., Finance & C.O.O. | 0 | 0 | Dec 07 2007 | |||
| McBarron Paul | E.V.P., Finance & C.O.O. | 76,054 | 377,988 | May 23 2008 | |||
| McBarron Paul | E.V.P.,Finance,C.F.O. & C.O.O. | 70,096 | 348,377 | Dec 10 2013 | |||
| McBarron Paul | E.V.P.,Finance,C.F.O. & C.O.O. | 0 | 0 | Feb 20 2015 | |||
| McBarron Paul | EVP, Finance, CFO, COO | 68,721 | 341,543 | Jan 29 2013 | |||
| McVie John Gordon | Director | 0 | 0 | Jul 11 2006 | |||
| McVie John Gordon | Director | 0 | 0 | Feb 21 2008 | |||
| MORGAN STANLEY | 10% Owner | 2,276,852 | 11,315,954 | Nov 12 2009 | |||
| NELSEN ROBERT | Director | 2,054,271 | 10,209,727 | Mar 23 2004 | |||
| NELSEN ROBERT | Director | 0 | 0 | Nov 02 2004 | |||
| NELSEN ROBERT | Director | 0 | 0 | Jun 17 2005 | |||
| Reyes Gregory | Senior VP, Research | 3,000 | 14,910 | Mar 21 2008 | |||
| Rombotis Spiro | President and CEO | 356,448 | 1,771,547 | Dec 15 2020 | |||
| Rombotis Spiro George | President & C.E.O. | 0 | 0 | Dec 07 2007 | |||
| Rombotis Spiro George | President & C.E.O. | 241,416 | 1,199,838 | Feb 20 2015 | |||
| Rombotis Spiro George | President & C.E.O. | 441,548 | 2,194,494 | Dec 04 2008 | |||
| Rombotis Spiro George | President & C.E.O. | 400 | 1,988 | Sep 14 2011 | |||
| Romel Lawrence A | VP Clinical Operations | 0 | 0 | Feb 07 2005 | |||
| SCHWARTZ BRIAN | Director | 0 | 0 | Dec 21 2020 | |||
| Sems Lloyd | Director | 0 | 0 | Jun 29 2020 | |||
| Sems Lloyd | Director | 0 | 0 | May 23 2014 | |||
| Sems Lloyd | Director | 0 | 0 | May 24 2012 | |||
| Sems Lloyd | Director | 33,333 | 165,665 | May 23 2013 | |||
| Sosnowski Robert Edward | VP, Marketing & Sales | 28,000 | 139,160 | Dec 08 2011 | |||
| Sosnowski Robert Edward | VP, Marketing & Sales | 0 | 0 | Dec 14 2010 | |||
| Spiegel Robert J. | Director | 0 | 0 | Jun 29 2020 | |||
| SPIEGELMAN DANIEL K | Director | 0 | 0 | Jul 11 2006 | |||
| SPIEGELMAN DANIEL K | Director | 0 | 0 | May 24 2012 | |||
| TANG KEVIN C | 10% Owner | 559,900 | 2,782,703 | Feb 27 2017 | |||
| UPRICHARD DAVID C | Director | 0 | 0 | Jun 29 2020 | |||
| UPRICHARD DAVID C | Director | 0 | 0 | May 23 2013 | |||
| UPRICHARD DAVID C | Director | 0 | 0 | May 23 2014 | |||
| UPRICHARD DAVID C | Director | 20,306 | 100,921 | Sep 15 2006 | |||
| UPRICHARD DAVID C | Director | 25,306 | 125,771 | May 26 2011 | |||
| Walker Karin L | Director | 0 | 0 | Nov 12 2020 | |||
| WERTHEIMER STEPHEN | Director | 574,363 | 2,854,584 | Mar 23 2004 | |||
| WERTHEIMER STEPHEN | Director | 0 | 0 | Jun 17 2005 | |||
| Westwood Robert | V.P., Chem. & Preclin. Dev. | 0 | 0 | Jul 11 2006 | |||
| Westwood Robert | V.P., Chem. & Preclin. Dev. | 0 | 0 | Dec 26 2006 | |||
| WILLIAMS ROBERT MICHAEL | Director | 45,700 | 227,129 | Jun 17 2005 | |||
| Womelsdorf Dr John Francis | VP, Business Development | 0 | 0 | Sep 05 2006 | |||
| Womelsdorf Dr John Francis | VP, Business Development | 0 | 0 | Oct 03 2006 | |||
| Womelsdorf Dr John Francis | VP, Business Development | 0 | 0 | Dec 07 2007 | |||
| Womelsdorf Dr John Francis | VP, Business Development | 2,100 | 10,437 | Mar 19 2008 | |||
| Womelsdorf Dr John Francis | VP, Business Development | 0 | 0 | Nov 20 2008 |